B. gibsoni B. gibsoni 3 病態 Babesia gibsoni B. gibsoni A B C D E F HK 2 疫学 B. gibsoni Polymerase chain reaction PCR B. gibsoni, PCR enzyme linked immun
|
|
|
- すずり きちや
- 7 years ago
- Views:
Transcription
1 総 説 小動物臨床関連部門 Canine babesiosis Masahiro YAMASAKI Veterinary Small Animal Internal Medicine, Iwate University, Ueda, Morioka, , Japan Canine babesiosis immune-mediated hemolytic anemia : IMHA 1 病因 Babesia gibsoni B. canis B. vogeli B. rossi B. conradae B. gibsoni B. gibsoni m. m B. gibsoni B. gibsoni ATP LK low kalium HK high kalium B. gibsoni HK Babesia gibsoni B. gibsoni B. gibsoni FAX masayama@iwate-u.ac.jp Correspondence to : Masahiro YAMASAKI (Veterinary Small Animal Internal Medicine, Iwate University) Ueda, Morioka, , Japan TEL FAX masayama@iwate-u.ac.jp
2 B. gibsoni B. gibsoni 3 病態 Babesia gibsoni B. gibsoni A B C D E F HK 2 疫学 B. gibsoni Polymerase chain reaction PCR B. gibsoni, PCR enzyme linked immunosorbent assay ELISA B. gibsoni, B. gibsoni
3 IMHA IMHA IMHA IMHA B. gibsoni ' nucleosidase ' nucleosidase B. gibsoni fibrinogen-like protein : FLP FLP 247 B. gibsoni disseminated intravascular coagulation : DIC fibrin/fibrinogen degradation product FDP D DIC 4 臨床所見一般徴候 :,, B. gibsoni 68
4 合併症 : B. rossi B. gibsoni B. gibsoni B. gibsoni B. rossi DIC ARDS Jacobson B. rossi Mohr B. gibsoni 5 診 断 B. gibsoni in situ hybridization B AmB AmB B. gibsoni AmB B. bovis B. rossi B. gibsoni B. gibsoni Acute respiratory distress syndrome : ARDS B. canis 臨床病理所見 :, 確定診断 : ph. B. gibsoni B. gibsoni,, indirect fluorescent antibody : IFA ELISA IFA,,
5 IMHA PCR,, 6 治療 diamidine mg/kg/day B. gibsoni B. gibsoni B. gibsoni Mepron 249 Babesia gisboni b a B. gibsoni mg/kg hours days. IM c. IM SC. IM b. IM b d. PO? d PO? e PO e Mepron. PO f. CRI B IM SC PO CRI B. gibsoni? a b c mg/kg d e f AmB AmB AmB AmB. mg/ml AmB AmB 68
6 mg/kg mg/kg mg/kg mg/kg in vitro in vivo B. gibsoni. mg/kg mg/kg, B. gibsoni mg/kg. mg/kg mg/kg B. gibsoni mg/kg/ day 7 予防 B. gibsoni 引用文献 Kuttler KL : World-wide impact of babesiosis, Babesiosis of domestic animals and man, Ristic M ed, CRC Press, Florida, Shaw SE, Lerga AI, Williams S, Beugnet F, Birtles RJ, Day MJ, Kenny MJ : Review of exotic infectious diseases in small animals entering the United Kingdom from abroad diagnosed by PCR, Vet Rec,, Taboada J, Merchant SR : Babesiosis of companion animals and man, Vet Clin North Am Small Anim Pract,, Taboada J, Lobetti R : Babesiosis, In Infectious disease of the dog and cat third edition, Saunders, St. Louis, Kjemtrup AM, Wainwright K, Miller M, Penzhorn BL, Carreno RA : Babesia conradae, sp. Nov., a small canine Babesia identified in California, Vet Parasitol,, Murase T, Hashimoto T, Ueda T, Maede Y : Multiplication of Babesia gibsoni in in vitro culture and its relation to hemolysis of infected erythrocytes, J Vet Med Sci,, Yamasaki M, Hossain MA, Jeong JR, Chang HS, Satoh H, Yamato O, Maede Y : Babesia gibsoni-specific isoenzymes related to energy metabolism of the parasites in infected erythrocytes, J Parasitol,, Murase T, Iwai M, Maede Y : Direct evidence for preferential multiplication of Babesia gibsoni in young
7 erythrocytes, Parasitol Res,, Yamasaki M, Otsuka Y, Yamato O, Tajima M, Maede Y : The cause of the predilection of Babesia gibsoni for reticulocytes, J Vet Med Sci,, Inaba M, Maede Y : Increase of Na+ gradient-dependent L-glutamate and L-aspertate transport in high K+ dog erythrocytes associated with high activity of (Na+,K+)-ATPase, J Biol Chem,, Yamasaki M, Asano H, Otsuka Y, Yamato O, Tajima M, Maede Y : Use of canine red blood cell with high concentrations of potassium, reduced glutathione, and free amino acid as host for in vitro cultivation of Babesia gibsoni, Am J Vet Res,, Inokuma H, Yoshizaki Y, Shimada Y, Sakata Y, Okuda M, Onishi T : Epidemiological survey of Babesia species in Japan performed with specimens from ticks collected from dogs and detection of new Babesia DNA closely related to Babesia odocoilei and Babesia divergens, J Clin Microbiol,, Iwakami S, Ichikawa Y, Inokuma H : Molecular survey of Babesia gibsoni using Haemaphysalis longicornis collected from dog and cats in Japan, J Vet Med Sci,, Miyata T, Sakata Y, Shimada Y, Ogino S, Watanabe M, Itamoto K, Okuda M, Verdida RA, Xuan X, Nagasawa H, Inokuma H : Epidemiological survey of Babesia gibsoni infection in dogs in eastern Japan, J Vet Med Sci,, Fukumoto S, Suzuki H, Igarashi I, Xuan X : Fatal experimental transplacental Babesia gibsoni infections in dogs, Int J Parasitol,, Konishi K, Sakata Y, Miyazaki N, Jia H, Goo YK, Xuan X, Inokuma H : Epidemiological survey of Babesia gibsoni infection in dogs in Japan by enzymelinked immunosorbent assay using B. gibsoni thrombospondin-related adhesive protein antigen, Vet Parasitol,, Yamasaki M, Harada E, Tamura Y, Lim SY, Ohsuga T, Yokoyama N, Morishita K, Nakamura K, Ohta H, Takiguchi M : In vitro and in vivo safety and efficacy studies of amphotericin B on Babesia gibsoni, Vet Parasitol,, Harvey JW, Taboada J, Lewis JC : Babesiosis in a litter of pups, J Am Vet Med Assoc,, Wright IG, Goodger BV : Pathogenesis of babesiosis, Ristic M ed, Babesiosis of domestic animals and man, CRC Press, Florida, Makinde MO, Bobade PA : Osmotic fragility of erythrocytes in clinically normal dogs and dogs with parasites, Res Vet Sci,, Adachi K, Tateishi M, Horii Y, Nagatomo H, Shimizu T, Makimura S : Reactivity of serum anti-erythrocyte membrane antibody in Babesia gibsoni-infected dogs, J Vet Med Sci,, Adachi K, Tateishi M, Horii Y, Nagatomo H, Shimizu T, Makimura S : Immunologic characteristics of anti- erythrocyte membrane antibody produced in dogs during Babesia gibsoni infection, J Vet Med Sci,, Adachi K, Yoshimoto A, Hasegawa T, Shimizu T, Goto Y, Makimura S : Anti-erythrocyte membrane antibodies detected in sera of dogs naturally infected with Babesia gibsoni, J Vet Med Sci,, Morita T, Saeki H, Imai S, Ishii T : Reactivity of antierythrocyte antibody induced by Babesia gibsoni infection against aged erythrocytes, Vet Parasitol,, Murase T, Maede Y : Increased erythrophagocytic activity of macrophages in dogs with Babesia gibsoni infection, Nippon Juigaku Zasshi,, Ohnishi T, Suzuki S : Changes of serum hemolytic activity and the number of reticulocytes in canine Babesia gibsoni infection, J Vet Med Sci,, Ohnishi T, Ueda K, Horie M, Kajikawa T, Ohnishi I : Serum hemolytic activity in dogs with Babesia gibsoni, J Parasitol,, Camacho AT, Pallas E, Gestal JJ, Guitian FJ, Olmeda AS : Natural infection by Babesia microti-like piroplasm in a splenectomised dog, Vet Rec,, Otsuka Y, Yamasaki M, Yamato O, Maede Y : The effect of macrophages on the erythrocyte oxidative damage and the pathogenesis of anemia in Babesia gibsoni-infected dogs with low parasitemia, J Vet Med Sci,, Murase T, Ueda T, Yamato O, Tajima M, Maede Y : Oxidative damage and enhanced erythrophagocytosis in canine erythrocytes infected with Babesia gibsoni, J Vet Med Sci,, Otsuka Y, Yamasaki M, Yamato O, Maede Y : Increased generation of superoxide in erythrocytes infected with Babesia gibsoni, J Vet Med Sci,, Hossain MA, Yamato O, Yamasaki M, Jeong JR, Chang HS, Maede Y : Serum from dogs infected with Babesia gibsoni inhibits maturation of reticulocytes and erythrocyte '-nucleotidase activity in vitro, J Vet Med Sci,, Chandoga P, Goldova M, Baranova D, Kozak M : First cases of canine babesiosis in the Slovak Republic, Vet Rec,, Abdullahi SU, Mohammed AA, Trimnell AR, Sannusi A, Alaflatayo R : Clinical and haematological findings in naturally occurring cases of canine babesiosis, J Small Anim Pract,, Irwin PJ, Hutchinson GW : Clinical and pathological findings of Babesia infection in dogs, Aust Vet J,, Casapulla R, Baldi L, Avallone V, Sannino R, Pazzanese L, Mizzoni V : Canine piroplasmosis due to Babesia gibsoni: Clinical and morphological aspects, Vet Rec,, Yamasaki M, Kobayashi Y, Nakamura K, Sasaki N,
8 Murakami M, Wickramasekara Rajapakshage BK, Ohta H, Yamato O, Maede Y, Takiguchi M : Babesia gibsoni: Detection in blood smears and formalinfixed, paraffin-embedded tissues using deoxyribonucleic acid in situ hybridization analysis, Exp Parasitol,, Jacobson LS : The South African form of severe and complicated canine babesiosis: clinical asvences, Vet Parasitol,, Jacobson LS, Clark IA : The pathophysiology of canine babesiosis: new approaches to an old puzzle, J S Afr Vet Assoc,, Daste T, Kycas MN, Aumann M : Cerebral babesiosis and acute respiratory distress syndrome in a dog, J Vet Emerg Crit Care,, Jacobson LS, Lobetti RG, Vaughan-Scott T : Blood pressure changes in dogs with babesiosis, J S Afr Vet Assoc,, Mohr B, Lobetti RG, Van der Lugt J : Acute pancreatitis: a rarely recognized complication of canine babesiosis, J S Afr Vet Assoc,, Reiter I, Weiland G : Recently developed methods for the detection of babesial infections, Trans R Soc Trop Med Hyg, (Suppl): Weiland G, Reiter I : Methods for the measurement of the serological response to Babesia, Ristic M ed, Babesiosis of domestic animals and man, CRC Press, Florida, Bobade PA, Oduye OO, Aghomo HO : Prevalence of antibodies against Babesia canis in dog in an endemic area, Rev Elev Med Vet Pays Trop,, Verdida RA, Hara OA, Xuan X, Fukumoto S, Igarashi I, Zhang S, Dong J, Inokuma H, Kabeya H, Sato Y, Morimoto T, Maruyama S, Claveria F, Nagasawa H : Serodiagnosis of Babesia gibsoni infection in dogs by an improved enzyme-linked immunosorbent assay with recombinant truncated P, J Vet Med Sci,, Ano H, Makimura S, Harasawa R : Detection of Babesia species from infected dog blood by polymerase chain reaction, J Vet Med Sci,, Fukumoto S, Xuan X, Shigeno S, Kimbita E, Igarashi I, Nagasawa H, Fujisaki K, Mikami T : Development of a polymerase chain reaction method for diagnosing Babesia gibsoni infection in dogs, J Vet Med Sci,, Inokuma H, Okuda M, Yoshizaki Y, Hiraoka H, Miyama T, Itamoto K, Une S, Nakaichi M, Taura Y : Clinical observations of Babesia gibsoni infection with low parasitemia confirmed by PCR in dogs, Vet Rec,, Song KH, Kim DH, Hayasaki M : The PCR-based detection of Babesia gibsoni infection in dogs (German shepherds) reared in South Korea, Ann Trop Med Parasitol,, Kuttler KL : Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis, J Am Vet Med Assoc,, Hwang SJ, Yamasaki M, Nakamura K, Sasaki N, Murakami M, Wickramasekara Rajapakshage BK, Ohta H, Maede Y : Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro, J Vet Med Sci,, Plumb DC : Diminazene aceturate, In Plumb s Veterinary Drug Handbook, th edition, PharmaVet Inc, Stockholm, Wisconsin, Abdullah AS, Sheikh-Omar AR, Baggot AR, Zamri M : Adverse effects of imidocarb dipropionate (Imizol ) in a dog, Vet Rec Commun,, Kuttler KL : Chemotherapy of babesiosis, Babesiosis of domestic animals and man, Ristic M ed, CRC press, Florida, Iguchi A, Matsuu A, Ikadai H, Talukder MD, Hikasa Y : Development of in vitro atovaquone-resistant Babesia gibsoni with a single-nucleotide polymorphism in cytb, Vet Parasitol,, Matsuu A, Koshida Y, Kawahara M, Inoue K, Ikadai H, Hikasa Y, Okano S, Higuchi S : Efficacy of atovaquone in vivo and in vitro, Vet Parasitol, Wulansari R, Wijaya A, Ano H, Horii Y, Makimura S : Clindamycin in the treatment of Babesia gibsoni infections in dogs, J Am Anim Hosp Assoc,, Wulansari R, Wijaya A, Ano H, Horii Y, Nasu T, Yamane S, Makimura S : Lymphocyte subsets and specific IgG antibody levels in clindamycin-treated and untreated dogs experimentally infected with Babesia gibsoni, J Vet Med Sci,, Suzuki K, Wakabayashi H, Takahashi M, Fukushima K, Yabuki A, Endo Y : A possible treatment strategy and clinical factors to estimate the treatment response in Babesia gibsoni infection, J Vet Med Sci,, Birkenheuer AJ, Neel J, Ruslander D, Levy MG, Breitschwerdt EB : Detection and molecular characterization of a novel large Babesia species in a dog, Vet Parasitol,, Jefferies R, Ryan UM, Jardine J, Robertson ID, Irwin PJ : Babesia gibsoni: Detection during experimental infections and after combined atovaquone and azithromycin therapy, Exp Parasitol,, Sakuma M, Setoguchi A, Endo Y : Possible emergence of drug resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin, J Vet Intern Med,, Lin ECY, Chueh LL, Lin CN, Hsieh LE, Su BL : The therapeutic efficacy of two antibabesial strategies against Babesia gibsoni, Vet Parasitol,, Masuda T, Baba E, Arakawa A : Relapse of canine babesiosis after prednisolone treatment, Mod Vet Pract,, Vercammen F, DeDeken R, Maes L : Prophylactic treatment of experimental canine babesiosis (Babesia canis) with doxycycline, Vet Parasitol,,
B. gibsoni././, P.../ P.../. /, BgTRAP ELISA,, B. gibsoni PCR B. gibsoni DNA 材料及び方法 犬血液 :, EDTANa B. gibsoni B. gibsoni PCR PCV RBCHGB WBC PLT ALT AST
原 著 Babesia gibsoni 小動物臨床関連部門 要 約 Babesia gibsoni BgTRAP ELISA, B. gibsoni... P. Babesia gibsoni BgTRAP ELISA Babesia spp., B. canis B. gibsoni, B. canis B. gibsoni B. gibsoni B. gibsoni, B. gibsoni,,
Atlas_j060419
Hill s Atlas of Veterinary Clinical Anatomy 1 29 30 2 3 4 5 31 32 33 34 35 36 37 6 7 8 9 10 11 12 13 38 39 40 41 14 15 16 17 18 19 20 21 22 23 24 25 26 27 42 43 44 45 46 47 48 49 50 51 52 53 54 55 28 81
Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection
Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Table 1. Bacterial cell counts in feces of mice infected with Esclwrichia coli O 157: H7 NK2 before and during oral dosing with fosfomycin
CHEMOTHERAPY AUG. 1982 VOL. 30 NO. 8 CHEMOTHERAPY Fig.1 Relation between various-closis of cefazolin and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection
Fig. 1 Chemical structure of DL-8280
Fig. 1 Chemical structure of DL-8280 Fig. 2 Susceptibility of cl in ical isolates to DL4280 Fig. 5 Susceptibility of clinical isolates to DL-8280 Fig. 3 Susceptibility of clinical isolates to DL-8280 Fig.
Table 1 Patients with various renal function * Ccr, Creatinine clearance ml/min per 1. 48 m2 ** C.V.D., Cerebral vascular disease ; C.R F., Chronic renal failure ; H.D., Hemoclialysis ; D., Dialyzer ;
VOL.32 S-9 CHEMOTHERAPY Table 1 Minimum inhibitory concentrations of AC-1370, CPZ and CAZ Table 2 Efficacy of AC-1370 and CPZ against systemic infections in mice *Inoculum size: 106 cells/ml * 95% confidence
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.
日本消化器外科学会雑誌第29巻第9号
Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe
CHEMOTHERAPY
CHEMOTHERAPY VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin CHEMOTHERAPY AUG. 1993 VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin Table 1. Comparative in vitro activity of teicoplanin
Key words : Tsutsugamushi disease, Rickettsia tsutsugamushi, serotype
Key words : Tsutsugamushi disease, Rickettsia tsutsugamushi, serotype Table 1 Characteristics of 44 patients with tsutsugamushi disease according to serotype of in- fected R. tsutsugarnushi Table 2 Laboratory
VOL. 34 S-2 CHEMOTH8RAPY 913
VOL. 34 S-2 CHEMOTH8RAPY 913 914 CHEMOTHERAPY APR. 1986 Fig. 1 Chemical structure of T-2588 and T-2525 T- 2588 pivaloyloxymethyl (+ )- (6 R, 7 R)-7-[(Z)-2- (2-amino- 4-thiazolyl)-2-methox yiminoacetamido]-3-[(
VOL. 36 S-3 CHEMOTHERAPY 437
VOL. 36 S-3 CHEMOTHERAPY 437 438 CHEMOTHERAPY JULY 1988 Fig. 1 Contractile response of gastrointestinal tract to intravenous administration of saline and EM in interdigestive state in dogs (a) : Saline,
CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates
VOL.39 S-1 CHEMOTHERAPY FEB. 1981 Table 1. Activity of cefpirome and others against clinical isolates VOL.39 S-1 CHEMOTHERAPY FEB. 1991 72 M, 55.5 kg 66 F, 53 kg Chronic bronchitis Bronchopneumonia Peak
VOL.42 S-1
CHEMOTHERAPY APR. 1994 VOL.42 S-1 CHEMOTHERAPY APR. 1994 Table 1. Criteria for evaluation of clinical efficacy by the Japanese Society of Oral and Maxillo-Facial Surgeons Grades of symptoms and numerical
Jpn.J.Leprosy 67, (1998)
Jpn.J.Leprosy 67,287-291(1998) Fig.1. Macroscopic appearance of the cultured slides stained by the Ziehl-Neelsen method. Up to bottom: kept at 4 C, 18 weeks, cultured for 6 weeks, 8 weeks, 10 weeks, 12
Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents
D 012 Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents DATA : 1 DATA : 2 3 DATA : UNGITEC 1 1 DATA : 20pg/mL 1020pg/mL 10pg/mL (cut off 20pg/mL) 90.2%(37/41) 100%(85/85) 96.8%(122/126)
988 CHEMOTHERAPY NOV. 1971
988 CHEMOTHERAPY NOV. 1971 VOL. 19 NO. 8 CHEMOTHERAPY 989 Effect of medium-ph and inoculum size on activity of SB-PC heart infusion agar, mcg/ml Sensitivity distribution of Staphylococci to SB-PC in surgical
VOL.39 S-3
VOL.39 S-3 CHEMOTHERAPY SEPT.1991 Table 1. Background of characteristics and allocation of 5 healthy male volunteers in a multiple-dose study on panipenem/betamipron Day 1 Fig. 1. Schedule of multiple-dose
慢性膵炎
- - 121 , g CCK g g - kgkcal kgkcal - g,,, - G.I.Res ; 10 : - ; 13 : - ; 22 : - Meier RF, Beglinger C. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol ; 20 : - Pfutzer RH, Schneider
CHEMOTHERAPY APRIL 1992 Table 2. Concentration of meropenem in human prostatic fluid Table 1. Background of 21 chronic complicated UTI cases * NB + BPH, NB + Kidney tumor, NB + Kidney tuberculosis Table
08-g-”O−}„j‹ê-4.02
200( 96 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 58 2 Apr. 585 1 17 MIC 1. (Transtracheal aspiration: TTA) TTA TTA TTA 1400 TTA (diffuse panbronchiolitis, DPB) 1) erythromycin(em) EM 12.5% 87.5% 2,3) EM EM
Table 1 Survival rates of infected mice given antibiotic doses producing peak serum a) S. aurcus Smith Challenge dose :7 ~10 (5% mucin) CFU/mouse. LD50: 1 ~103 (5% mucin) CFU/mouse. Table 2 Survival rates
Fig. 1 Chemical structure of KW-1070
Fig. 1 Chemical structure of KW-1070 Fig. 2 Sensitivity distribution of clinical isolates Fig. 4 Sensitivity distribution of clinical isolates Fig. 3 Sensitivity distribution of clinical isolates Fig.
coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F
VOL.43 S-1 coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, Flavobacter- Table 1. Concentration of grepafloxacin
CHEMOTHERAPY
CHEMOTHERAPY CHEMOTHERAPY Table 1 Antibacterial activity of BRL 28500 against standard strains of bacteria Fig, 1 Sensitivity distribution of ABPC-resistant E. coli isolated from urinary tract Fig. 2 Sensitivity
Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination
Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination Fig. 1 The value of fungal index and D- arabinitol/creatinine. Fungal index was mesured by Endotoxin D and Endospecy
5 CSF 6 CSF 7 CSF CSF CDV CDV GFAP CSF Pandy test NSE MBP LDH mu/ml 0-5 /µl AST mu/ml CK mu/ml <25 mg/dl<45 mg/dl GLU
CT MRI CSFCSF CSF CSF CSF CSF CSF (cisternal puncture) CSF 20-23G 90 (20-23G) : CSF
CHEMOTHERAPY APRIL 1992 VOL. 40 S- 1 Table 1-1. Comparative in vitro activity of meropenem against clinical isolates CNS: coagulase-negative staphylococci CHEMOTHERAPY APRIL 1992 Table 1-2. Comparative
Microsoft Word - 「黄砂とその健康影響について」小冊子180323版
...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html
CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus
VOL. 32 S-4 CHEMOTHERAPY Fig. 1 Chemical structure of sodium cefoperazone Fig. 2 Chemical structure of sodium cefoperazone CHEMOTHERAPY JUN. 1984 Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter
5) Corn meal Agar Corn meal @ 40 Agar @ 20 6) Corn Meal Blood Agar 7) Agar 8) Blood Agar Saccharide @ 30.0 NaNO3 @ 2.0 K2HPO4 @ 1.0 MgSO47H2O @ 0.5 KC1 @ 0.5 F2SO47H2O @ 0.01 Agar @ 30.0 11) Mueller Hinton
Key words: pure red cell anemia, allogeneic bone marrow transplantation.
Complete Recovery of Hemopoiesis Following Bone Marrow Transplantation in a Patient with Unresponsive Congenital Pure Red Cell Anemia Masami SHIMADA, Hideo MUGISHIMA, Mitsuhiko HARA, Masahiro MISAWA, Hideo
Letter566.pdf
http://nibs.lin.gr.jp/ 2 2 29 1000 1990 27.4 30.0 2009 13.5 49.6 1995 475 87 2009 292 332 1995 54 22 2009 70 101 57 1 2011 3 3 13 2008 3 2009 5 11 6 4.5 2 cm 3 1 1 2 3 S 100 4 Vimentin Melan A 5 3 HE Canine
37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate
37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5
400 46 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec. 2012 LVFX 100 mg 3 / 7 150 mg 2 / 7 2 2006 2008 9 LVFX PK PD 2009 7 100 mg 1 3 500 mg 1 1 AUC/MIC
Dec. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 399 45 2012 11 5 LVFX 500 mg 1 1 20 Chlamydia trachomatis C. trachomatismycoplasma genitalium M. genitalium LVFX 1 500 mg 1 1 7 22 22 C. trachomatis 17
/‚“1/ŒxŒ{‚×›î’æ’¶
60 1 pp.3-8 2010 1. H1N1 1) 2) 3) 4) ERATO 2009 H1N1 21 H1N1 HA PB2 2009 3 Pandemic H1N1 2009 WHO 6 11 21 2009 11 2010 4 21 H1N1 H1N1 2009 4 15 CDC 108-8639 4-6-1 TEL: 03-5449-5281 FAX: 03-5449-5408 E-mail:
untitled
ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504
1272 CHEMOTHERAPY MAR. 1975
1272 CHEMOTHERAPY MAR. 1975 VOL. 23 NO. 3 CHEMOTHERAPY 1273 Fig. 2 Minimal inhibitory concentration of aminoglycosides against 50 strains of Klebsiella Fig. 1 Minimal inhibitory concentration of aminoglycosides
Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.
Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S. Table 1. Clinical summary of acute uncomplicated cystitis patients treated with 7432-S UTI : Criteria by the
DNA
1 1 1. 1 2. 2 3. 2 4. 2 2 1. 2 4 5 7 2. 7 3. DNA 8 4. 10 13 Plasmodium (P. falciparum) (P. vivax) (P. malariae) P. ovale 4 40% 200 7 40 48 72 1. - 1 - 2. DNA 3 3. 1) 2) 3) 4) 4. 1 1) - 2 - 2) EDTA 1) 1
semen quality or those without WBC in semen. In the patients with azoospermia and normal FSH levels (normogonadotropic azzospermia), the antibody (IgG
CLINICAL STUDIES OF UROGENITAL INFECTIONS WITH CHLAMYDIA TRACHOMA TIS Report 2. The Epidemiology of Chlamydial Infections in Okayama District in Japan and Detection of Antibodies to Chlamydiae in the Sera
1) Kojima H: Culture of ejaculate for Neisseria gonorrhoeae, 1st Serually Transmitted Diseases World Congress, San Juan, 11. 19, 1981. 9) Kojima H, Mori C: Clinical studies on Conococcal and Chlamydial
CHEMOTHERAPY Fig. 1 Chemical structure of TE-031
CHEMOTHERAPY Fig. 1 Chemical structure of TE-031 CHEMOTHERAPY Table 1 Experimental groups for active systemic anaphylaxis in guinea pigs : Single dosage Fig. 2 Schedule for active systemic anaphylaxis
Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates
Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates Table 2-1. Summary of patients treated with grepafloxacin for respiratory infection 1) Out: outpatient,
PDFfl[ŁiŠp_Œ{Ł¶…g…fi…{Łt‡«.pdf
診断 治療 技術講座 2018; 29 4 : 413-420 APTT 波形解析 APTT waveform Hideo WADA Key words: APTT, waveform, hemophilia, anticoagulant therapy 1978 1982 1982 1983 1985 NIH 1985 2000 / 2008 1 activated partial thromboplastin
1 見出し1，12ポ，日本語ゴシック，英語Arial，段落後は6ポの設定です
8. Page1 8. B 1 5) 6) 2099 2370 50 400 mg 19 (1) 1) (a) 78.9% 30/38 4 3 35.7% 5/14 71.4% 10/1485.7% 12/142 1 83.3% 5/63 2 1 1 1 8. Page2 (b) 2099 1897 82.4% 1562/1897 2 84.0% 1298/1545 3 2 80.4% 472/58779.0%
Table1MIC of BAY o 9867 against standard strains
Table1MIC of BAY o 9867 against standard strains Fig.2Cumulative and Distribution Curves of MIC (S.aureus 54 strains) 106cfu/ml Fig.3Correlogram of MIC (S.aureus 54 strains) CHEMOTHERAPY 451 Fig.4Cumulative
Key words : R-plasmid, Urinary tract infection, E. coli Fig. 1. MIC distribution against E. coli isolated from urinary tract (366 strains) and isolation - frequencies of drug-resistant strains Table 1.
Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi
Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi Shinomiya and Tetsuo Kanno Department of Neurosurgery,
VOL. 17 NO. 7 CHEMOTHERAPY 1305 1) W. BRumFirr et al. : Clinical and laboratory studies with carbenicillin. Lancet 1: 1289~ 1293, 1967 2) E. T. KNUDSEN et al. : A new semisynthetic penicillin active against
研究成果報告書(基金分)
(1) 種類 程度 肥満細胞数の測定と組織でのサ RT-PCR FACS () (1) NMU-/- IgE NMU IgE -/-NMU -/-B IgE NMU -/-B6 IgE NMU NMU CTLMC BMMC IgE NMU CTLMC 13 1. Hayakawa J, Mizukawa Y, Kurata M, Shiohara T: A syringotropic variant
顔面神経麻痺を来したMPO―ANCA 陽性の中耳炎２症例
11367 : MPOANCA MPO ANCA MPOANCA 134EU MPO ANCA 67EU MPOANCA ANCA : MPOANCAANCA antineutrophil cytoplasmic antibody ; ANCA Davies IgG ANCA PR3proteinase3ANCA MPOmyeloperoxidaseANCA Wegener PR3ANCA MPO
AAS48.indd
Suzuki K. (2016). Breeding for disease resistance to Mycoplasma pneumonia of swine All about SWINE 48, 2-12 PRDC ARMPS PRRS 18 1 21 24 32 40 MPS EU 2006 2011 SPF 2 3 MPS 5 MPS 4 MPS MPS MPS 2 MPS MPS MPS
E Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian
CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX
Fig. 1 Chemical structure of CXM-AX NOV. 1986 Fig. 2 Sensitivity distribution of clinical isolates organisms (106 cells/ml) a Smurcus 27 strains d) P.m irabilis 15 strains b Ecol i 27 strains 111.morganii
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration
VOL. 21 NO. 2 CHEMOTHERAPY 395
394 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 395 396 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 397 398 CHEMOTHERAPY MAR. 1973 VOL. 2 1 NO. 2 CHEMOTHERAPY 399 400 CHEMOTHERAPY MAR. 1973
CHEMOTHERAPY JUNE 1986
VOL. 34 S-3 CHEMOTHERAPY Fig. 1 Structural formula of L-105 CHEMOTHERAPY JUNE 1986 VOL. 34 S-3 CHEMOTHERAPY Table 1 Antibacterial spectra of L-105 against gram negative anaerobic rods Inoculum 106 cells/ml
Key words: ELISA method, streptococcal antibody, Anti-M protein antibody, whole cell antigen Table 2 Uptake of protein A using different anti-group sera of streptococci Figure shows optical density at
Key words: change serotype, Pseudomonas aeruginosa anti-pseudomonal drug,
Key words: change serotype, Pseudomonas aeruginosa anti-pseudomonal drug, Table 1 Incidence of changes in serotype of Pseudomonas aeruginosa isolates induced by anti-pseudomonal drugs Number of isolates
2) Dolphin, A., Jenner, P., Marsden, C,D., Pycock, C. and Tarsy, D. : Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents, Psychopharmacologia, 41 : 133, 1975.
VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity
VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity CHEMOTHERAPY MAR. 1989 Mble 1. Allcrgy in parients nduced by penams VOL. 37 NO. 3 Table 2. Allergy in patients induced by
Clinical Observation and Etiological Aspect on the Thrombocytopenic Purpura after Rubella Toyoji SODA, Masashi KAWANO, Toshihiko KATO*, and Takeshi SH
Clinical Observation and Etiological Aspect on the Thrombocytopenic Purpura after Rubella Toyoji SODA, Masashi KAWANO, Toshihiko KATO*, and Takeshi SHIGEMATSU**, Rubella is an acute viral infectious disease
Key words: Legionella, urinary antigen, enzymeimmunoassay (EIA), rapid diagnosis
Key words: Legionella, urinary antigen, enzymeimmunoassay (EIA), rapid diagnosis lymerase chain reaction(pcr) EIA kit Table1 @ Reference strains used in this study Table2 @ Comparison between Biotest and
Fig.1 MICs of penicillins against 24 strains of B. pertussis Fig.2 MICs of cepherns against 24 strains of B. pertussis Fig.3 MICs of macrolides against 24 strains of B. pertussis Fig.4 MICs of nalidixic
VOL. 40 S- 1 Table 1. Susceptibility of methicillin-resistant Staphylococcus aureus to meropenem Table 2. Coagulase typing of methicillin-resistant St
CHEMOTHERAPY VOL. 40 S- 1 Table 1. Susceptibility of methicillin-resistant Staphylococcus aureus to meropenem Table 2. Coagulase typing of methicillin-resistant Staphylococcus aureus CHEMOTHERAPY Table
7) G. N., A. A. Sondore et al.: The Use of Hyperbaric Oxygenation in Intensive Therapy of Patients with Liver Damage. VI Int. Cong. HBO Medicine, Moscow, Sept 2 `6:341, 1981 8) J. J. Moder, M. D.: Phagocytic
untitled
---------- - 1 - ----- 1 Q1 5 Q2 5 Q3 5 Q4 6 Q5 6 Q6 7 Q7 7 Q8 7 Q9 8 Q10 : 8 10 Q1 10 Q2 11 Q3 11 12 Q4 12 Q5 HBs HBc _12 Q6 HBe 12 Q7 13 Q8 NAT 15 Q9 15 Q10 15 Q11 HBs 16 Q12 HBV DNA 16 Q13 17-2 - Q14
1) Delbet P: Retrocissement du choledoque. Cholecysto-duodenostomie. Bull Mem Soc Nat Chir 50: 1144-1146, 1924 2) Wiesner RH, LaRusso NF: Clinicopathologic Features of the Syndrome of Primary Sclerosing
1 2 D- D- 1206 D- D- -2003 120 /2004 D-FDA GRAS D D- 3 5 5 D- 75 10g/kg 14 40 20 D-101520 90 1520 20%101520 1520 D- 5(D- 2300-6700mg//) () 2024 615 D- 41220g/kg/ 1220g/kg/ 20g/kg/ 1220g/kg/ () 50 D- 10%
A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc
A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, School of Medicine, Tokushima University, Tokushima Fetal
VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human
CHEMOTHERAPY Fig. 1 Chemical structure of carumonam Disodium(+)-(Z)-CCE1-(2-amino-4-thiazoly1)-2-[[(2S, -(carbamoyloxymethyl)-4-oxo-1-sulfonato-3-azetidinyll -2-oxoethylidene] amino] oxy] acetate 3S)-2
jsfm_著者紹介_160520
Sarah M. A. Caney 1 European Journal of Companion Animal Practice (2015) Autumn 25 (3) EJCAP 25(3) Special issue 2015 P4 Commissioned paper* Management of the elderly cat Sarah M. A. Caney 1-01 - EJCAP
a) DifcoTM Brain Heart Infusion agar, DifcoTM Brain Heart Infusion, Becton, Dickinson and Company, U.S.A.
a) DifcoTM Brain Heart Infusion agar, DifcoTM Brain Heart Infusion, Becton, Dickinson and Company, U.S.A. [1] Buttenschon J, Svensmark B, Kyrval J: Zentralb Veterinarmedizin A, 42, 633-641 (1995) [2]
9 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /,, No.0,,/+,/0 (,**/) 251 * * E#ects of Microbial Transglutaminase on Melting Point and Gel property of G
9 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /,, No.0,,/+,/0 (,**/) 251 * * E#ects of Microbial Transglutaminase on Melting Point and Gel property of Gelatins Takahiko Soeda, Tomoko Kaneko*, Akiko Hokazono,
CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote
aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Proteus mirabilis 3.13, Proteus vulgaris 1.56, Citrobacter freundii 0.39,
Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL Right Posted at the Inst
Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL http://hdl.handle.net/10130/526 Right Posted at the Institutional Resources for Unique Colle Available from
特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書（案）
VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.
Fig. 1 Chemical structure of norfioxacin (AM-715)
Fig. 1 Chemical structure of norfioxacin (AM-715) Table 1 Serum and biliary concentration of norfloxacin (AM-715) Table 2 Protocol for clinical evaluation of norfloxacin (AM-715) in the treatment of biliary
STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U
STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical University, Kashihara (Director: Prof. H. Nakano) This
2) Goetz, A., Tsuneishi, N.: Application of molecular filter membranes to the bacteriological analysis of water, J. Am. Water Works Assn., 43 (12): 943-969,1951. 3) Clark, H.F. et al.: The membrane filter
VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega
1066 CHEMOTHERAPY MAR. 1975 Table 1 Sensitivity of standard strains VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity
研究成果報告書
X-SCID T NK Omenn T T 2007 2008 0menn T 1. 研究開始当初の背景 T T T T reversion T T 2. 研究の目的 RAG1/RAG2 Artemis T TCR T TCR 3. 研究の方法 RAG1/RAG2 μ μ μ μ μ μμ μμ μ 解析ダイアグラム 3-D display による TCR 多様性の評価 4. 研究成果 TCR T
Epizootics of Getah Virus Infection i n Horses in the Kanto Region of Japan in 1983 Takeo SUGIURA, * YOShio FUKUNAGA* and Kiyoshi HIRASAWA* Over a per
Epizootics of Getah Virus Infection i n Horses in the Kanto Region of Japan in 1983 Takeo SUGIURA, * YOShio FUKUNAGA* and Kiyoshi HIRASAWA* Over a period from the middle of August to that of September
CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin
CHEMOTHERAPY CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin CHEMOTHERAPY Fig. 1 MICs of sultamicillin against respiratory pathogenic Branhamella catarrhalis 62 strains, inoculum size 106CFU/m1 Fig.
1315 (15)
(14) 1315 (15) 1316 (16) 1317 (17) 1318 (18) 1319 (19) 1320 (20) 1321 (21) 1322 quinidine, disopyramide, and procainamide in isolated atrial myocytes : Mediation by 2) Inoue H, et al: Effects of pentisomide
CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A
CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A 15 180 306 7,000 1 3 mg 103 92 89.3 60 60 100 173 28 16.2 3.52.92.3 1.7 1.7 1.7 2 64 78 80 3 ST 4 5 32 6 18 65 CQ 1 307 1 7,000 2006 ; 94 11 : 2149-2168. 2 2010
Staphylococcus sp. K.pneumoniae P.mirabilis C.freundii E. cloacae Serratia sp. P. aeruginosa ml, Enterococcus avium >100ƒÊg/ml
CHEMOTHERAPY SEPT. 1992 cefoperazone ceftazidime (CAZ), imipenem (IPM) Staphylococcus sp., Enterococcus (CPZ), faecalis, Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii, Enterobacter cloacae,
1. King, V. L., Y. Koketsu, D. Reeves, JL. Xue, G. D. Dial.: Management factors associated with swine breeding herd productivity in the USA. Prey. Vet. Med. 35 : 255-264, 1998. 2. Koketsu, Y., J. E. Pettigrew,
Key words : influenza, nested-pcr, serotype
Key words : influenza, nested-pcr, serotype Table 1 Sequence of PCR primers used to detect HA gene of influenza virus 524 清水 Fig. 1 Detection of PCR product 英明 他 (lstpcr) Table 2 Results method Fig. 2
教室業績2014
MFICU MFICU : - : - : -,,, : - : -- - : - : - : - - - : - - - - : - : - : - : -, : - Takano Y, Furukawa S, Ohashi M, Michikata K, Sameshima H, Ikenoue T J Obstet Gynaecol Res, : -, CTG - CTG - : - Katsuragi
26 1 : Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hira
26 1 : 35 45 2017 1 2 2 2 2 2 2 2 2 1 1 2 Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hirayama 1, Yoko Nakajo 2, Akemi Saito 2, Rie Hatakeyama
Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45)
Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 2305(45) 2306(46) THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 Dec. Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII-12 2307(47) 2308(48) THE JAPANESE
硫酸アルミニウムカリウムタンニン酸注射液（ALTA）による内痔核硬化療法後にフルニエ症候群をきたした1例 第65巻02号0075頁
65 V A Case Report of Fournier s Gangrene after Sclerosing Therapy for Internal Hemorrhoids with Aluminum Potassium Sulfate and Tannic Acid (ALTA) Injection Aluminum potassium sulfate and tannic acid
15) Egawa, R., Sawai, T. and Mit.uhashi, S.: Jap. J. Microbiol., 11 : 173-178, 1967. 16) Tanaka, T. and Hashimoto, H., Nagai, Y. and Mitsuhashi, S.: Jap. J. Microbiol., 11: 155-162, 1967. 17) Mitsuhashi,
45 40 : Blood transfusion(100ml) PCV(%) Days Prednisolone Mesalazine Chlorambucil Cyclospo
短 報 要 約 colonic vascular ectasia : CVE estrogen-progesteron EP EP, 症例. kg PCV. CBC PCV.. MCV. fl MCHC. g/dl. / l, / l X 臨床経過と治療 ml ml PCV mg/kg SID A B FAX E-mail : chikazaw@vmas.kitasato-u.ac.jp 767 45
VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains )
CHEMOTHERAPY OCT. 1984 Fig. I Chemical structure of CTRX VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains ) CHEMOTHERAPY Fig. 3 Cumulative
X DV LR RA RV LA LV ALP IU/l PS, PS BV BV. kg. mg/kg, BID, PO. mg/kg, BID, PO. mg/kg, SC. mg/kg, IV mg/kg, IV Fr Fr mm Amplatz COOK Japan mm cm Tyshak
短 報 要 約. m/s. mmhg 背景 Pulmonic stenosis : PS, Ventricular septal defect : VSD PS VSD Balloon valvuloplasty : BV 症例. kg Grade VI/VI X DV CTR. D LR VHS. v mm mm. m/s. mmhg. mm. m/s PS VSD FAX E-mail : fujiiy@azabu-u.ac.jp
Table 1 Epidemiologic characteristics in the elderly patients with sepsis Table 2 Main underlying disease
Key words: elderly patient, sepsis, multiple organ failure (MOF) Table 1 Epidemiologic characteristics in the elderly patients with sepsis 1985-1994 Table 2 Main underlying disease Fig. 1 The yearly frequency